Sunday 18 October 2026 Export CCCC’s income statement to Excel — free account

C4 Therapeutics, Inc.

C4 Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $35.9 million, up 1.02% from fiscal 2024. In the quarter to June 2026, revenue grew 2.75%, EPS grew 51.4% and free cash flow grew 86.8%, each against the same quarter a year earlier.

2.77 0.01 −0.36%

Follow CCCC

Alert me

Market cap: $342.0M
P/E: 0.0×
Fwd P/E: −4.1×
Dividend yield: —
F-score: 4/9
Altman Z: −2.16
Beneish M: −2.61
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		5.35	4.40	9.51	17.42
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(5.16)	(7.15)	(11.07)	(387.77)
P/B ratio Full definition →		1.04	0.62	1.42	2.47
Price to Tangible BV Full definition →		1.04	0.62	1.42	2.47
EV/Sales Full definition →		(0.39)	(1.98)	3.29	10.72
EV/EBITDA Full definition →		0.09	0.61	0.00	0.00
EV/Operating CF Full definition →		0.13	0.72	(1.20)	(4.43)
EV/FCF Full definition →		0.12	0.72	(1.20)	(4.40)
Quick Ratio Full definition →		5.52	7.60	8.75	5.29
Current Ratio Full definition →		5.76	7.81	9.00	5.45
Net Debt/EBITDA Full definition →		5.57	10.54	8.28	9.64
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.09	0.10	0.11	0.11
Operating CF/Net income Full definition →		0.97	1.08	1.19	0.07
Capex/Depreciation Full definition →		7.47	0.03	0.09	(0.35)
Interest Coverage Full definition →		—	4.61	10.46	9.48
Research and Development Expense of Revenue Full definition →		231.42%	226.78%	399.97%	368.48%
Selling, General and Administrative Expense of Revenue Full definition →		79.43%	83.32%	151.67%	129.39%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		40.90%	36.37%	43.42%	45.72%
Graham Net Nets Full definition →		0.59	0.98	0.45	0.25
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(75.23%)	(71.20%)	(45.25%)	(21.41%)
Free Cash Flow Yield Full definition →		(59.01%)	(62.72%)	(28.96%)	(13.99%)
Revenue per Share Full definition →		0.15	0.13	0.05	0.05
Operating CF per Share Full definition →		(0.43)	(0.27)	(0.24)	(0.01)
Capex per Share Full definition →		(0.01)	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.44)	(0.27)	(0.24)	(0.01)
Cash per Share Full definition →		2.64	3.00	1.87	1.94
Shareholders Equity per Share Full definition →		2.13	3.10	1.86	1.89
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		2.13	3.10	1.86	1.89
Free Cash Flow Full definition →		(31.62)	(22.16)	(30.01)	(1.61)
Working Capital Full definition →		170.92	225.08	218.12	214.66
Capital Expenditures Full definition →		(0.41)	(0.01)	(0.06)	(0.04)
Net Current Asset Value Full definition →		95.78	155.62	150.76	150.76
EV/EBIT Full definition →		0.09	0.62	0.00	0.00
Capex to Sales Full definition →		0.04	0.00	0.01	0.01
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		8.44	2.75	5.46	1.75
Average Payables Full definition →		1.42	1.09	0.73	1.67
Average Assets Full definition →		320.77	354.34	324.19	327.97
Average Common Equity Full definition →		198.53	236.29	214.69	210.66

Show all line items

Columns are period end dates

Stockrow Weekly